Textextraktion: pypdf | Seiten: 5
1 Decision of the Court of First Instance of the Unified Patent Court issued on 8 January 2025 CLAIMANT Dexcom Inc., 6340 Sequence Drive, CA 92121 San Diego, USA, represented by CEO Kevin Sayer, at the same address, represented by: Dr Marcus Grosch, Quinn Emanuel, Hermann -Sack-Straße 3, 80331 Munich, Germany. DEFENDANTS 1. Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064 -6400, USA, represented by its board of directors which is represented by the CEO Robert Ford; 2. Abbott Diabetes Care Inc., 1360 South Loop Road, Alameda, California 94502, USA, represented by its president Jared Watkin; 3. Abbott GmbH, Max-Planck-Ring 2, 65205 Wiesbaden, Germany, represented by its managing directors Robert Funck, Konstantinos Varlas and Christian Grapow; 4. Abbott Diagnostics GmbH ...